Nuzenio

Fresenius Announces Fda

Fresenius Announces Fda news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Barclays Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 09:06:00 GMTFresenius SE price target lowered to EUR 55.20 from EUR 56.60 at JPMorgan - tipranks.comtipranks.com · Fri, 07 Aug 2026 03:21:25 GMTFresenius SE & Co. KGaA (FRE.F) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 11:25:17 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business WireBusiness Wire · Mon, 03 Aug 2026 20:09:00 GMTPolpharma and Fresenius Kabi's Vedolizumab Biosimilar PB016 Clears FDA, EMA Review Acceptance - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 16:17:12 GMTFresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTPolpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate - Business WireBusiness Wire · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 09:06:00 GMTBarclays Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9) - The Globe and Mail
Fri, 07 Aug 2026 03:21:25 GMTFresenius SE price target lowered to EUR 55.20 from EUR 56.60 at JPMorgan - tipranks.com
Thu, 06 Aug 2026 11:25:17 GMTFresenius SE & Co. KGaA (FRE.F) stock price, news, quote and history - Yahoo Finance Singapore
Mon, 03 Aug 2026 20:09:00 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business Wire
Fri, 31 Jul 2026 16:17:12 GMTPolpharma and Fresenius Kabi's Vedolizumab Biosimilar PB016 Clears FDA, EMA Review Acceptance - BioPharm International
Fri, 31 Jul 2026 07:00:00 GMTFresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fresenius Announces Fda.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.